Protein research firm closes on funding

March 15, 2004 — NextGen Sciences Ltd., a Cambridgeshire, England, developer of devices for microarray analysis in proteomics research, announced it closed on a round of funding.

The amount was not disclosed. The investment was led by Create Partners and an unnamed group of German investors.

The company said it will use the funds to support commercialization efforts of two recently launched products. NextGen appointed Boyd Mulvey of Create Partners to its board of directors.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.